Additionally, a significant proportion of patients did not receive pharmacological treatment with ACE inhibitors (ACEIs) or angiotensin II receptor blockers (ARBs), despite clinical practice guidelines recommending their use in HF patients to improve survival [23,24]. Here, ACE is linked to hydrops fetalis.